Cargando…

Arthritis following COVID-19 vaccination: report of two cases

While most patients with coronavirus disease 2019 (COVID-19) present with mild or moderate symptoms, 15% may develop severe pneumonia, 5% develop acute respiratory distress syndrome (ARDS), septic shock, and multiple organ failure. Some patients may also experience arthralgia or arthritis. Cases of...

Descripción completa

Detalles Bibliográficos
Autor principal: Unal Enginar, Ayse
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516724/
https://www.ncbi.nlm.nih.gov/pubmed/34673298
http://dx.doi.org/10.1016/j.intimp.2021.108256
_version_ 1784583856547954688
author Unal Enginar, Ayse
author_facet Unal Enginar, Ayse
author_sort Unal Enginar, Ayse
collection PubMed
description While most patients with coronavirus disease 2019 (COVID-19) present with mild or moderate symptoms, 15% may develop severe pneumonia, 5% develop acute respiratory distress syndrome (ARDS), septic shock, and multiple organ failure. Some patients may also experience arthralgia or arthritis. Cases of reactive arthritis have been reported during or after COVID-19. With the approval of the use of COVID-19 vaccines, the vaccination program was started in our country and is still continuing.Here we present two patients who developed arthritis after COVID-19 vaccination.
format Online
Article
Text
id pubmed-8516724
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-85167242021-10-15 Arthritis following COVID-19 vaccination: report of two cases Unal Enginar, Ayse Int Immunopharmacol Article While most patients with coronavirus disease 2019 (COVID-19) present with mild or moderate symptoms, 15% may develop severe pneumonia, 5% develop acute respiratory distress syndrome (ARDS), septic shock, and multiple organ failure. Some patients may also experience arthralgia or arthritis. Cases of reactive arthritis have been reported during or after COVID-19. With the approval of the use of COVID-19 vaccines, the vaccination program was started in our country and is still continuing.Here we present two patients who developed arthritis after COVID-19 vaccination. Elsevier B.V. 2021-12 2021-10-15 /pmc/articles/PMC8516724/ /pubmed/34673298 http://dx.doi.org/10.1016/j.intimp.2021.108256 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Unal Enginar, Ayse
Arthritis following COVID-19 vaccination: report of two cases
title Arthritis following COVID-19 vaccination: report of two cases
title_full Arthritis following COVID-19 vaccination: report of two cases
title_fullStr Arthritis following COVID-19 vaccination: report of two cases
title_full_unstemmed Arthritis following COVID-19 vaccination: report of two cases
title_short Arthritis following COVID-19 vaccination: report of two cases
title_sort arthritis following covid-19 vaccination: report of two cases
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516724/
https://www.ncbi.nlm.nih.gov/pubmed/34673298
http://dx.doi.org/10.1016/j.intimp.2021.108256
work_keys_str_mv AT unalenginarayse arthritisfollowingcovid19vaccinationreportoftwocases